3PLs set specialty pharmaceutical markets in motion
Managing the physical movement of specialty drugs calls for dedicated services
One of the attributes of the burgeoning specialty pharmaceutical market in the US is that many of the products are moving through distribution channels via nontraditional channels. Part of this is due to their very nature—they often require special handling (such as temperature-controlled, refrigerated transportation and storage). Part of this is due to the growth of alternative sites of dispensing—infusion centers, outpatient clinics and most of all specialty pharmacies (SPs), a rapidly growing category of retail pharmacy. But the most fundamental reason, it seems, is the combination of financial and business-relationship arrangements between manufacturers, payers and providers that, in some cases, affords better opportunities to access the market for manufacturers, and cost savings or streamlined operations for payers.
Source: Pharmaceutical Commerce